Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population.

MLA

Gordon, Stuart C., et al. “Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population.” Clinical Gastroenterology & Hepatology, vol. 12, no. 5, May 2014, pp. 885–93. EBSCOhost, https://doi.org/10.1016/j.cgh.2013.09.062.

APA

Gordon, S. C., Lamerato, L. E., Rupp, L. B., Li, J., Holmberg, S. D., Moorman, A. C., Spradling, P. R., Teshale, E. H., Vijayadeva, V., Boscarino, J. A., Henkle, E. M., Oja, T. N., & Lu, M. (2014). Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population. Clinical Gastroenterology & Hepatology, 12(5), 885–893. https://doi.org/10.1016/j.cgh.2013.09.062

Chicago

Gordon, Stuart C., Lois E. Lamerato, Loralee B. Rupp, Jia Li, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, et al. 2014. “Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population.” Clinical Gastroenterology & Hepatology 12 (5): 885–93. doi:10.1016/j.cgh.2013.09.062.